StayCurrentMD · Ernica Clinical Consensus Statements on Total Colonic and Intestinal Aganglionosis
Article1 min read·Published Apr 2024Older

Ernica Clinical Consensus Statements on Total Colonic and Intestinal Aganglionosis

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Apr 2024 · 1 min read

In brief

In brief

This consensus statement from ERNICA addresses surgical and long-term management strategies for total colonic and intestinal aganglionosis, rare and severe variants of Hirschsprung disease affecting less than 10% of patients. The document provides clinical guidance on surgical approaches, management of bowel dysfunction, and ongoing care for these life-threatening congenital conditions.

  • Total colonic aganglionosis (TCA) and total intestinal aganglionosis (TIA) affect <10% of Hirschsprung patients but are life-threatening.
  • TCA involves absent ganglion cells throughout the colon; TIA extends into variable lengths of small bowel.
  • ERNICA consensus addresses surgical treatment strategies for both TCA and TIA as distinct clinical entities.
  • Management of poor bowel function post-operatively is a critical focus area requiring specialized protocols.
  • Long-term follow-up protocols are essential for TCA/TIA patients due to ongoing functional challenges.

Written by the GCMD Library team from the article.

Hirschsprung disease is a congenital intestinal motility disorder characterized by an absence of enteric ganglion cells. Total colonic aganglionosis and near total or total intestinal aganglionosis, defined as absence of ganglion cells in the entire colon and with variable length of small bowel involved, are life-threatening conditions which affect less than 10 % of all patients with Hirschsprung disease. The aim of this project was to develop clinical consensus statements within ERNICA, the European Reference Network for rare congenital digestive diseases, on four major topics: Surgical treatment of total colonic aganglionosis, surgical treatment of total intestinal aganglionosis, management of poor bowel function in total colonic and/or intestinal aganglionosis and long-term management in total colonic and or intestinal aganglionosis.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →